PBMCs from patients with AD or HC were incubated with CpG and CD40L for 48 h, respectively, and then PMA/ionomycin and brefeldin A were added for the last 5 h before the assessment of intracellular IL-10 expression. Here, IL10 is linked to Alzheimer disease.